PCN34 COST-EFFECTIVENESS OF ANASTROZOLE OVERTAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER FROM A UK NATIONAL HEALTH SERVICE PERSPECTIVE- THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL

Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67272-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)67272-5/fulltext
Title : PCN34 COST-EFFECTIVENESS OF ANASTROZOLE OVERTAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER FROM A UK NATIONAL HEALTH SERVICE PERSPECTIVE- THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67272-5&doi=10.1016/S1098-3015(10)67272-5
First page :
Section Title :
Open access? : No
Section Order : 502
Categories :
Tags :
Regions :
ViH Article Tags :